Stalveo is used to treat Parkinson's disease. It contains a combination of levodopa, carbidopa, and entacapone. These ingredients work together to increase dopamine levels in the brain, which is responsible for regulating movement and controlling motor symptoms such as tremors, stiffness, slowness of movement, and lack of balance. This helps patients improve their daily activities and reduce the suffering caused by the progression of the disease.
Stalveo also combines multiple active ingredients, which prolongs the duration of the treatment's effect, maintains its stability in the bloodstream, and reduces periods of decreased response to treatment, known as the "off effect" phenomenon. With regular use according to the doctor's instructions, patients can achieve significant improvement in motor symptoms and regain greater flexibility and activity. This medication is an effective and reliable treatment option that provides Parkinson's patients with essential support in controlling symptoms.